0.3269
price down icon0.97%   -0.0032
after-market Handel nachbörslich: .32 -0.0069 -2.11%
loading
Schlusskurs vom Vortag:
$0.3301
Offen:
$0.34
24-Stunden-Volumen:
1.29M
Relative Volume:
1.33
Marktkapitalisierung:
$5.18M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.07M
KGV:
-0.0566
EPS:
-5.78
Netto-Cashflow:
$-7.34M
1W Leistung:
-30.42%
1M Leistung:
-50.36%
6M Leistung:
-70.01%
1J Leistung:
-68.72%
1-Tages-Spanne:
Value
$0.3206
$0.348
1-Wochen-Bereich:
Value
$0.2715
$0.405
52-Wochen-Spanne:
Value
$0.22
$3.00

Adial Pharmaceuticals Inc Stock (ADIL) Company Profile

Name
Firmenname
Adial Pharmaceuticals Inc
Name
Telefon
434-422-9800
Name
Adresse
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Name
Mitarbeiter
7
Name
Twitter
@AdialPharma
Name
Nächster Verdiensttermin
2024-12-12
Name
Neueste SEC-Einreichungen
Name
ADIL's Discussions on Twitter

Vergleichen Sie ADIL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ADIL
Adial Pharmaceuticals Inc
0.3269 5.18M 0 -6.07M -7.34M -5.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-14 Eingeleitet Rodman & Renshaw Buy
2018-10-30 Eingeleitet Maxim Group Buy
2018-10-11 Eingeleitet Dawson James Buy

Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten

pulisher
Jun 17, 2025

Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Adial Pharmaceuticals (ADIL) Announces Public Offering to Raise $3.6M - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Adial Pharmaceuticals prices $3.6 million public offering - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Adial Pharmaceuticals (ADIL) Sets Pricing for Stock and Warrants Offering | ADIL Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering | ADIL Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Adial Pharmaceuticals prices $3.6 million public offering By Investing.com - Investing.com Nigeria

Jun 17, 2025
pulisher
Jun 17, 2025

Adial Pharmaceuticals Secures $3.6M Financing: New Shares at $0.32 Plus Warrant Package - Stock Titan

Jun 17, 2025
pulisher
Jun 17, 2025

Adial Pharmaceuticals Announces New Annual Meeting Date By Investing.com - Investing.com Nigeria

Jun 17, 2025
pulisher
Jun 16, 2025

Adial Pharmaceuticals Announces New Annual Meeting Date - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

Adial Pharmaceuticals Reschedules 2025 Annual Meeting Date - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Adial Pharmaceuticals Inc (ADIL) Stock: From Low to High in 52 Weeks - investchronicle.com

Jun 16, 2025
pulisher
Jun 16, 2025

Adial Pharmaceuticals (ADIL) Advances Toward Phase 3 with FDA Meeting Preparation | ADIL Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Adial Pharmaceuticals Submits Briefing Package to Guide Upcoming FDA Meeting - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

Market Update: Adial Pharmaceuticals Inc (ADIL) Sees Negative Movement, Closing at 0.35 - DWinneX

Jun 16, 2025
pulisher
Jun 15, 2025

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 63.0% in May - Defense World

Jun 15, 2025
pulisher
Jun 11, 2025

ADIL Stock on the Rise: A Promising Investment - investchronicle.com

Jun 11, 2025
pulisher
Jun 11, 2025

Adial Pharmaceuticals advances Phase 3 trial design for alcohol disorder drug By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing - AOL.com

Jun 11, 2025
pulisher
Jun 11, 2025

Adial Pharmaceuticals advances Phase 3 trial design for alcohol disorder drug - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Adial Pharmaceuticals (ADIL) Advances Phase 3 Trial Plans for AD04 | ADIL Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04 - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Revolutionary AI-Powered Phase 3 Trial: How Adial Plans to Transform Alcohol Addiction Treatment - Stock Titan

Jun 11, 2025
pulisher
Jun 11, 2025

EXCLUSIVE: Adial Pharmaceuticals Lead Candidate For Alcohol Use Disorder Advances Toward Phase 3 Trial - Yahoo Finance

Jun 11, 2025
pulisher
Jun 06, 2025

ADIL: A.G.P./Alliance Global Partners Appointed as Sole Placemen - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

ADIL: A.G.P./Alliance Global Partners Appointed as Sole Placement Agent | ADIL Stock News - GuruFocus

Jun 06, 2025
pulisher
May 30, 2025

Adial Pharmaceuticals (ADIL) Files to Sell Over 6 Million Shares - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Adial Pharmaceuticals Faces Nasdaq Non-Compliance Notice - TipRanks

May 30, 2025
pulisher
May 30, 2025

Adial Pharmaceuticals (ADIL) Files to Sell Over 6 Million Shares | ADIL Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Update - Defense World

May 30, 2025
pulisher
May 19, 2025

ADIL Q2 EPS Increased by Brookline Capital Management - Defense World

May 19, 2025
pulisher
May 16, 2025

Adial Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025
pulisher
May 16, 2025

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 16, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals sets new proposal deadline By Investing.com - Investing.com Nigeria

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals sets new proposal deadline - Investing.com

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals (ADIL) Reports Q1 2025 Results | ADIL Stoc - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals Reports First Quarter 2025 Financial Resul - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals (ADIL) Reports Q1 2025 Results | ADIL Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update | ADIL Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals Q1 2025 Financial Results and Business Update - TradingView

May 15, 2025
pulisher
May 15, 2025

Adial Pharmaceuticals Advances AUD Drug to Phase 3, Cuts Losses by 66% in Q1 2025 Earnings - Stock Titan

May 15, 2025
pulisher
May 14, 2025

ADIAL PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Adial Pharmaceuticals (ADIL) Receives Milestone Payment for Asth - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Adial Pharmaceuticals (ADIL) Receives Milestone Payment for Asthma Drug Development | ADIL Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study - The Manila Times

May 13, 2025
pulisher
May 11, 2025

Adial Pharmaceuticals (ADIL) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 09, 2025

FDA to Review Adial’s Phase 3 Trial Plan for AUD Treatment - Investing.com Nigeria

May 09, 2025
pulisher
May 08, 2025

FDA Has Granted Request for End of Phase 2 Meeting to Discuss Alcohol Use Disorder Treatment, AD04 - Psychiatric Times

May 08, 2025
pulisher
May 08, 2025

FDA to Review Adial’s Phase 3 Trial Plan for AUD Treatment By Investing.com - Investing.com South Africa

May 08, 2025
pulisher
May 08, 2025

Adial Pharmaceuticals Granted End Of Phase 2 Meeting From FDA - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

EXCLUSIVE: Adial Pharmaceuticals Secures FDA End of Phase 2 Meeting Request To Discuss Upcoming Clinical Development Plan For Lead Program - AOL.com

May 08, 2025
pulisher
May 08, 2025

Adial Pharmaceuticals (ADIL) Receives FDA Green Light for Phase 3 Meeting | ADIL Stock News - GuruFocus

May 08, 2025

Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):